Global and United States CXCR4 Antagonists Market Report & Forecast 2023-2028

Report ID: 1873858 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 CXCR4 Antagonists Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million) Introduction
    1.2 Global CXCR4 Antagonists Outlook 2017 VS 2022 VS 2028
        1.2.1 Global CXCR4 Antagonists Market Size for the Year 2017-2028
        1.2.2 Global CXCR4 Antagonists Market Size for the Year 2017-2028
    1.3 CXCR4 Antagonists Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States CXCR4 Antagonists in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of CXCR4 Antagonists Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 CXCR4 Antagonists Market Dynamics
        1.4.1 CXCR4 Antagonists Industry Trends
        1.4.2 CXCR4 Antagonists Market Drivers
        1.4.3 CXCR4 Antagonists Market Challenges
        1.4.4 CXCR4 Antagonists Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 CXCR4 Antagonists by Type
    2.1 CXCR4 Antagonists Market Segment by Type
        2.1.1 BL-8040
        2.1.2 GMI-1359
        2.1.3 Plerixafor (AMD3100)
        2.1.4 Balixafortide (POL6326)
        2.1.5 USL311
        2.1.6 Others
    2.2 Global CXCR4 Antagonists Market Size by Type (2017, 2022 & 2028)
    2.3 Global CXCR4 Antagonists Market Size by Type (2017-2028)
    2.4 United States CXCR4 Antagonists Market Size by Type (2017, 2022 & 2028)
    2.5 United States CXCR4 Antagonists Market Size by Type (2017-2028)
3 CXCR4 Antagonists by Application
    3.1 CXCR4 Antagonists Market Segment by Application
        3.1.1 Cancer
        3.1.2 HIV
        3.1.3 Chronic Inflammatory Diseases
    3.2 Global CXCR4 Antagonists Market Size by Application (2017, 2022 & 2028)
    3.3 Global CXCR4 Antagonists Market Size by Application (2017-2028)
    3.4 United States CXCR4 Antagonists Market Size by Application (2017, 2022 & 2028)
    3.5 United States CXCR4 Antagonists Market Size by Application (2017-2028)
4 Global CXCR4 Antagonists Competitor Landscape by Company
    4.1 Global CXCR4 Antagonists Market Size by Company
        4.1.1 Top Global CXCR4 Antagonists Companies Ranked by Revenue (2021)
        4.1.2 Global CXCR4 Antagonists Revenue by Player (2017-2022)
    4.2 Global CXCR4 Antagonists Concentration Ratio (CR)
        4.2.1 CXCR4 Antagonists Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of CXCR4 Antagonists in 2021
        4.2.3 Global CXCR4 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global CXCR4 Antagonists Headquarters, Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million) Type
        4.3.1 Global CXCR4 Antagonists Headquarters and Area Served
        4.3.2 Global CXCR4 Antagonists Companies Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into CXCR4 Antagonists Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States CXCR4 Antagonists Market Size by Company
        4.5.1 Top CXCR4 Antagonists Players in United States, Ranked by Revenue (2021)
        4.5.2 United States CXCR4 Antagonists Revenue by Players (2020, 2021 & 2022)
5 Global CXCR4 Antagonists Market Size by Region
    5.1 Global CXCR4 Antagonists Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global CXCR4 Antagonists Market Size by Region (2017-2028)
        5.2.1 Global CXCR4 Antagonists Market Size by Region: 2017-2022
        5.2.2 Global CXCR4 Antagonists Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America CXCR4 Antagonists Market Size YoY Growth 2017-2028
        6.1.2 North America CXCR4 Antagonists Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific CXCR4 Antagonists Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific CXCR4 Antagonists Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe CXCR4 Antagonists Market Size YoY Growth 2017-2028
        6.3.2 Europe CXCR4 Antagonists Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America CXCR4 Antagonists Market Size YoY Growth 2017-2028
        6.4.2 Latin America CXCR4 Antagonists Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa CXCR4 Antagonists Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa CXCR4 Antagonists Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Details
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi CXCR4 Antagonists Introduction
        7.1.4 Sanofi Revenue in CXCR4 Antagonists Business (2017-2022)
        7.1.5 Sanofi Recent Development
    7.2 BioLineRx
        7.2.1 BioLineRx Company Details
        7.2.2 BioLineRx Business Overview
        7.2.3 BioLineRx CXCR4 Antagonists Introduction
        7.2.4 BioLineRx Revenue in CXCR4 Antagonists Business (2017-2022)
        7.2.5 BioLineRx Recent Development
    7.3 X4 Pharmaceuticals
        7.3.1 X4 Pharmaceuticals Company Details
        7.3.2 X4 Pharmaceuticals Business Overview
        7.3.3 X4 Pharmaceuticals CXCR4 Antagonists Introduction
        7.3.4 X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2017-2022)
        7.3.5 X4 Pharmaceuticals Recent Development
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Details
        7.4.2 Eli Lilly Business Overview
        7.4.3 Eli Lilly CXCR4 Antagonists Introduction
        7.4.4 Eli Lilly Revenue in CXCR4 Antagonists Business (2017-2022)
        7.4.5 Eli Lilly Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche CXCR4 Antagonists Introduction
        7.5.4 Roche Revenue in CXCR4 Antagonists Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 Merck
        7.6.1 Merck Company Details
        7.6.2 Merck Business Overview
        7.6.3 Merck CXCR4 Antagonists Introduction
        7.6.4 Merck Revenue in CXCR4 Antagonists Business (2017-2022)
        7.6.5 Merck Recent Development
    7.7 Biokine Therapeutics
        7.7.1 Biokine Therapeutics Company Details
        7.7.2 Biokine Therapeutics Business Overview
        7.7.3 Biokine Therapeutics CXCR4 Antagonists Introduction
        7.7.4 Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2017-2022)
        7.7.5 Biokine Therapeutics Recent Development
    7.8 GlycoMimetics
        7.8.1 GlycoMimetics Company Details
        7.8.2 GlycoMimetics Business Overview
        7.8.3 GlycoMimetics CXCR4 Antagonists Introduction
        7.8.4 GlycoMimetics Revenue in CXCR4 Antagonists Business (2017-2022)
        7.8.5 GlycoMimetics Recent Development
    7.9 Harmonic Pharma
        7.9.1 Harmonic Pharma Company Details
        7.9.2 Harmonic Pharma Business Overview
        7.9.3 Harmonic Pharma CXCR4 Antagonists Introduction
        7.9.4 Harmonic Pharma Revenue in CXCR4 Antagonists Business (2017-2022)
        7.9.5 Harmonic Pharma Recent Development
    7.10 Upsher-Smith Laboratories
        7.10.1 Upsher-Smith Laboratories Company Details
        7.10.2 Upsher-Smith Laboratories Business Overview
        7.10.3 Upsher-Smith Laboratories CXCR4 Antagonists Introduction
        7.10.4 Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2017-2022)
        7.10.5 Upsher-Smith Laboratories Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. CXCR4 Antagonists Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. CXCR4 Antagonists Market Trends
    Table 3. CXCR4 Antagonists Market Drivers
    Table 4. CXCR4 Antagonists Market Challenges
    Table 5. CXCR4 Antagonists Market Restraints
    Table 6. Global CXCR4 Antagonists Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States CXCR4 Antagonists Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global CXCR4 Antagonists Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States CXCR4 Antagonists Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top CXCR4 Antagonists Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global CXCR4 Antagonists Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global CXCR4 Antagonists Revenue Share by Player, 2017-2022
    Table 13. Global CXCR4 Antagonists Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global CXCR4 Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2021)
    Table 15. Top Players of CXCR4 Antagonists in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into CXCR4 Antagonists Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top CXCR4 Antagonists Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States CXCR4 Antagonists Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States CXCR4 Antagonists Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global CXCR4 Antagonists Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global CXCR4 Antagonists Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global CXCR4 Antagonists Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America CXCR4 Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific CXCR4 Antagonists Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe CXCR4 Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa CXCR4 Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa CXCR4 Antagonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Sanofi Company Details
    Table 31. Sanofi Business Overview
    Table 32. Sanofi CXCR4 Antagonists Product
    Table 33. Sanofi Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 34. Sanofi Recent Development
    Table 35. BioLineRx Company Details
    Table 36. BioLineRx Business Overview
    Table 37. BioLineRx CXCR4 Antagonists Product
    Table 38. BioLineRx Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 39. BioLineRx Recent Development
    Table 40. X4 Pharmaceuticals Company Details
    Table 41. X4 Pharmaceuticals Business Overview
    Table 42. X4 Pharmaceuticals CXCR4 Antagonists Product
    Table 43. X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 44. X4 Pharmaceuticals Recent Development
    Table 45. Eli Lilly Company Details
    Table 46. Eli Lilly Business Overview
    Table 47. Eli Lilly CXCR4 Antagonists Product
    Table 48. Eli Lilly Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 49. Eli Lilly Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche CXCR4 Antagonists Product
    Table 53. Roche Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Merck Company Details
    Table 56. Merck Business Overview
    Table 57. Merck CXCR4 Antagonists Product
    Table 58. Merck Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 59. Merck Recent Development
    Table 60. Biokine Therapeutics Company Details
    Table 61. Biokine Therapeutics Business Overview
    Table 62. Biokine Therapeutics CXCR4 Antagonists Product
    Table 63. Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 64. Biokine Therapeutics Recent Development
    Table 65. GlycoMimetics Company Details
    Table 66. GlycoMimetics Business Overview
    Table 67. GlycoMimetics CXCR4 Antagonists Product
    Table 68. GlycoMimetics Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 69. GlycoMimetics Recent Development
    Table 70. Harmonic Pharma Company Details
    Table 71. Harmonic Pharma Business Overview
    Table 72. Harmonic Pharma CXCR4 Antagonists Product
    Table 73. Harmonic Pharma Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 74. Harmonic Pharma Recent Development
    Table 75. Upsher-Smith Laboratories Company Details
    Table 76. Upsher-Smith Laboratories Business Overview
    Table 77. Upsher-Smith Laboratories CXCR4 Antagonists Product
    Table 78. Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2017-2022) & (US$ Million)
    Table 79. Upsher-Smith Laboratories Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. CXCR4 Antagonists Product Picture
    Figure 2. Global CXCR4 Antagonists Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global CXCR4 Antagonists Market Size 2017-2028 (US$ Million)
    Figure 4. United States CXCR4 Antagonists Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States CXCR4 Antagonists Market Size 2017-2028 (US$ Million)
    Figure 6. United States CXCR4 Antagonists Market Share in Global 2017-2028
    Figure 7. CXCR4 Antagonists Report Years Considered
    Figure 8. Product Picture of BL-8040
    Figure 9. Product Picture of GMI-1359
    Figure 10. Product Picture of Plerixafor (AMD3100)
    Figure 11. Product Picture of Balixafortide (POL6326)
    Figure 12. Product Picture of USL311
    Figure 13. Product Picture of Others
    Figure 14. Global CXCR4 Antagonists Market Share by Type in 2022 & 2028
    Figure 15. Global CXCR4 Antagonists Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global CXCR4 Antagonists Market Share by Type (2017-2028)
    Figure 17. United States CXCR4 Antagonists Market Share by Type in 2022 & 2028
    Figure 18. United States CXCR4 Antagonists Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States CXCR4 Antagonists Market Share by Type (2017-2028)
    Figure 20. Product Picture of Cancer
    Figure 21. Product Picture of HIV
    Figure 22. Product Picture of Chronic Inflammatory Diseases
    Figure 23. Global CXCR4 Antagonists Market Share by Application in 2022 & 2028
    Figure 24. Global CXCR4 Antagonists Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global CXCR4 Antagonists Market Share by Application (2017-2028)
    Figure 26. United States CXCR4 Antagonists Market Share by Application in 2022 & 2028
    Figure 27. United States CXCR4 Antagonists Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States CXCR4 Antagonists Market Share by Application (2017-2028)
    Figure 29. North America CXCR4 Antagonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe CXCR4 Antagonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific CXCR4 Antagonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America CXCR4 Antagonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa CXCR4 Antagonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E CXCR4 Antagonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Sanofi Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 58. BioLineRx Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 59. X4 Pharmaceuticals Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 60. Eli Lilly Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 61. Roche Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 63. Biokine Therapeutics Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 64. GlycoMimetics Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 65. Harmonic Pharma Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 66. Upsher-Smith Laboratories Revenue Growth Rate in CXCR4 Antagonists Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
BioLineRx
X4 Pharmaceuticals
Eli Lilly
Roche
Merck
Biokine Therapeutics
GlycoMimetics
Harmonic Pharma
Upsher-Smith Laboratories
Frequently Asked Questions
CXCR4 Antagonists report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CXCR4 Antagonists report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CXCR4 Antagonists report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sunflower Headers

Sunflower Headers market is segmented by region (country), players, by Type and by Application. P ... Read More

Corn Headers

Corn Headers market is segmented by region (country), players, by Type and by Application. Player ... Read More

Gravity Filters

Gravity Filters market is segmented by region (country), players, by Type and by Application. Pla ... Read More